![](https://ml-eu.globenewswire.com/media/1464b205-f24e-4ae8-ab69-85968b38d774/small/mdg-logo-2016-gray-rgb-jpg.jpg)
Medigene to Present at ESMO Congress 2024
Planegg/Martinsried, July 23, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today announced the …